Operative Techniques in Thoracic and Cardiovascular Surgery: A Comparative Atlas
Volume 11, Issue 1 , Pages 57-75 , Spring 2006

Treatment of Malignant Pleural Mesothelioma: Pleurectomy with Adjuvant Therapy

  • Raja M. Flores, MD

      Affiliations

    • Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Corresponding Author InformationAddress reprint requests to Raja M. Flores, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-879, New York, New York 10021
  • ,
  • Naveed Alam, MD

      Affiliations

    • Peter MacCallum Cancer Centre and St. Vincent’s Hospital, Melbourne, Australia

References 

  1. Wagner JC , Sleggs CA , Marchand P . Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province . Br J In Med . 1960;17:260–271
  2. Butchart EG , Ashcroft T , Barnsley WC , et al.   Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura (experience with 29 patients) . Thorax . 1976;31:15–24
  3. Sugarbaker DJ , Jaklitsch MT , Bueno R , et al.   Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies . J Thor CV Surg . 2004;128:138–145
  4. Heelan RT , Rusch VW , Begg CB , et al.   Staging of malignant pleural mesothelioma (comparison of CT and MR imaging) . AJR Am J Roentgenol . 1999;172:1039–1047
  5. Benard F , Sterman D , Smith RJ , et al.   Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography . Chest . 1998;114:713–722
  6. Flores RM , Akhurst T , Gonen M , et al.   Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma . J Thorac Cardiovasc Surg . 2003;126:11–15
  7. Flores RM , Akhurst T , Gonen M , et al.   FDG-PET predicts survival in patients with malignant pleural mesothelioma . Proc Am Soc Clin Oncol . 2003;22:620; (abstract)
  8. Rusch VW . Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma . Semin Thorac Cardiovasc Surg . 1997;9:367–372
  9. McCormack PM , Nagasaki F , Hilaris BS , et al.   Surgical treatment of pleural mesothelioma . Thorac Cardiovasc Surg . 1982;84:834–842
  10. Alberts AS , Falkson G , Goedhals L , et al.   Malignant pleural mesothelioma (a disease unaffected by current therapeutic maneuvers) . J Clin Oncol . 1988;6:527–535
  11. Mattson K , Holsti LR , Tammilehto L , et al.   Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation . Int J Radiat Oncol Biol Phys . 1992;24:643–650
  12. Lee TT , Everett DL , Shu HK , et al.   Radical pleurectomy/decortication and intra-operative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma . J Thorac Cardiovasc Surg . 2002;124:1074–1077
  13. Rusch VW , Saltz L , Venkatraman E , et al.   A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma . J Clin Oncol . 1994;12:1156–1163
  14. Rice TW , Adelstein DJ , Kirby TJ , et al.   Aggressive multimodality therapy for malignant pleural mesothelioma . Ann Thorac Surg . 1994;58:24–29
  15. Lee JD , Perez S , Wang HJ , et al.   Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma (the UCLA experience) . J Surg Oncol . 1995;60:262–267
  16. Colleoni M , Sartori F , Calabro F , et al.   Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma . Tumori . 1996;82:53–56
  17. Hastürk S , Tastepe I , Unlu M , et al.   Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients . J Chemother . 1996;8:159–164
  18. Cresoli GL , Locati L , Ferreri AJ , et al.   Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma . Lung Cancer . 2001;34:279–287
  19. Carry PY , Brachet A , Gilly FN , et al.   A new device for the treatment of pleural malignancies (intrapleural chemohyperthermia preliminary report) . Oncology . 1993;50:348–352
  20. Ratto GB , Civalleri D , Esposito M , et al.   Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma (a feasibility and pharmacokinetic study) . Thorac Cardiovasc Surg . 1999;117:759–765
  21. de Bree E , van Ruth S , Baas P , et al.   Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma . Chest . 2002;121:480–487
  22. Sugarbaker D , Richards WG , Zellos LS , et al.   Feasibility of pleurectomy and intraoperative bicavitary hyperthermic cisplatin lavage for mesothelioma (a phase I-II study) . Proc Am Soc Clin Oncol . 2003;22:620; (abstract)
  23. Pass HI , Temeck BK , Kranda K , et al.   Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma . Ann Surg Oncol . 1997;4:628–633
  24. Moskal TL , Dougherty TJ , Urschel JD , et al.   Operation and photodynamic therapy for pleural mesothelioma (6-year follow-up) . Ann Thorac Surg . 1998;66:1128–1133

PII: S1522-2942(06)00027-4

doi: 10.1053/j.optechstcvs.2006.02.002

Operative Techniques in Thoracic and Cardiovascular Surgery: A Comparative Atlas
Volume 11, Issue 1 , Pages 57-75 , Spring 2006